Concentration of total mycophenolic acid (MPA), mycophenolic acid glucuronide (MPAG) and unbound MPA in diabetic kidney transplant recipients.

被引：0
|
作者：
Akhlaghi, F
Patel, CG
Zuinga, P
Lin, S
Yango, A
Gohh, R
机构：
[1] Univ Rhode Isl, Coll Pharm, Kingston, RI 02881 USA
[2] Rhode Isl Hosp, Brown Med Sch, Providence, RI USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2004年 / 4卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
268
引用
收藏
页码：232 / 232
页数：1
相关论文
共 50 条
  • [31] OPTIMISATION OF MYCOPHENOLIC ACID (MPA) EXPOSURE FOR EARLY STEROID WITHDRAWAL IN KIDNEY GRAFT RECIPIENTS: THE OPERA TRIAL
    Le Meur, Y.
    Touchard, G.
    Glowacki, F.
    Rerolle, J. P.
    Garrigue, V.
    Ouali, N.
    Heng, A. E.
    Delahousse, M.
    Albano, L.
    Couzi, L.
    Lang, P.
    Westeel, P. F.
    Allano, F.
    Tagieva, N.
    Rostaing, L.
    TRANSPLANT INTERNATIONAL, 2009, 22 : 7 - 7
  • [32] Overestimation of mycophenolic acid by EMIT correlates with MPA metabolite
    Shipkova, M
    Schütz, E
    Armstrong, VW
    Niedmann, PD
    Wieland, E
    Oellerich, M
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 1135 - 1137
  • [33] Mycophenolic acid monitoring:: Evaluation of the EMIT MPA immunoassay in kidney and lung transplantation
    Brunet, M
    Oppenheimer, F
    Martorell, J
    Vilardell, J
    Carreño, MC
    Carrillo, M
    Corbella, J
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (06) : 2275 - 2276
  • [34] Optimizing Mycophenolic Acid Exposure in Kidney Transplant Recipients: Time for Target Concentration Intervention
    Metz, David K.
    Holford, Nick
    Kausman, Joshua Y.
    Walker, Amanda
    Cranswick, Noel
    Staatz, Christine E.
    Barraclough, Katherine A.
    Ierino, Francesco
    TRANSPLANTATION, 2019, 103 (10) : 2012 - 2030
  • [35] Influence of cyclosporine exposure on the pharmacokinetics of mycophenolic acid in renal transplant recipients.
    Sudchada, Patcharaporn
    Gundroo, Aijaz
    Donneally, Julie
    DeFrancesco, Robin
    Hochreiter, Jill
    Venuto, Rocco
    Tornatore, Kathleen M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 593 - 593
  • [36] Identification of an active metabolite of mycophenolic acid in plasma of liver transplant recipients.
    Schütz, E
    Shipkova, M
    Armstrong, VW
    Wieland, E
    Oellerich, M
    HEPATOLOGY, 1998, 28 (04) : 739A - 739A
  • [37] Mycophenolic Acid May Reduce Donor Specific HLA Antibody Strength in Kidney Transplant Recipients.
    Rebellato, Lorita M.
    Zadeh, Sousan
    Ozawa, Mikki
    Parker, Karen
    Briley, Kimberly P.
    Catrou, Paul G.
    Bolin, Paul
    Kendrick, William
    Haisch, Carl E.
    Terasaki, Paul I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 641 - 641
  • [38] The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-O-glucuronide
    Naesens, Maarten
    de Loor, Henriette
    Vanrenterghem, Yves
    Kuypers, Dirk R. J.
    TRANSPLANTATION, 2007, 84 (03) : 362 - 373
  • [39] Chronopharmacokinetics of Mycophenolic Acid and Its Glucuronide and Acyl Glucuronide Metabolites in Kidney Transplant Recipients Converted From Cyclosporine to Everolimus
    Tedesco-Silva, Helio, Jr.
    Felipe, Claudia Rosso
    Slade, Alan
    Schmouder, Robert L.
    Medina Pestana, Jose Osmar
    THERAPEUTIC DRUG MONITORING, 2012, 34 (06) : 652 - 659
  • [40] Population pharmacokinetic modeling for mycophenolic acid and its main glucuronide metabolite in Chinese kidney transplant recipients
    YANG Chun-lan
    SHENG Chang-cheng
    FENG Li-juan
    JIAO Zheng
    XU Du-juan
    中国药理学与毒理学杂志, 2019, (10) : 817 - 817
12345